Status:

UNKNOWN

D Tc 99m Dimercaptosuccinic Acid SPECT Versus Planar

Lead Sponsor:

Assiut University

Conditions:

Dimercaptosuccinic Acid SPECT and Planar

Eligibility:

All Genders

Brief Summary

Knowing what will DMSA spect add to the DMSA planar in detection in renal cortical defects

Eligibility Criteria

Inclusion

  • patient with history of peylo nephritis.

Exclusion

  • pregnant women

Key Trial Info

Start Date :

September 1 2019

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

October 1 2020

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT04091685

Start Date

September 1 2019

End Date

October 1 2020

Last Update

September 17 2019

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

D Tc 99m Dimercaptosuccinic Acid SPECT Versus Planar | DecenTrialz